A federal court temporarily overturned provisions of a new Florida legislation on Tuesday, declaring that "gender identity is real" and finding no justification for the state to prevent transgender adolescents from getting cross-sex hormones and puberty blockers.
In a preliminary order, Judge Robert Hinkle ruled that three transgender children may continue to receive care. The Republican governor Ron DeSantis signed the measure under challenge just before launching his candidacy for president.
"It's important to acknowledge the elephant in the room right away. Real gender identity exists. Hinkle stated in his decision that "the record makes this plain," and even a state witness concurred. Although it has been accessible for more than ten years and is supported by significant medical groups, transgender medical therapy for kids is coming under more and more criticism, according to Hinkle.
The law prohibits treating children with "GnRH agonists, commonly referred to as puberty blockers, and cross-sex hormones." The "treatments at question include GnRH agonists, commonly referred to as "puberty blockers," and cross-sex hormones," according to Hinkle.
In accordance with the situation, Hinkle said, "the overwhelming weight of medical authority supports the treatment of transgender patients with GnRH agonists and cross-sex hormones." Considering that "competent specialists have appropriately evaluated the children's medical problems and requirements in accordance with the well-established standards of care," he predicted that the plaintiffs will win their case.
Hinkle ordered a preliminary injunction against the defendants that said, in part, "the preliminarily enjoined parties shall not take any actions to hinder the delivery of GnRH agonists or cross-sex hormones" for the three kids.
Gender identity proponents "tend to dislike all things transgender and, as a result, oppose medical care that supports a person's transgender life," according to Hinkle.
Hinkle asserted that forbidding therapy overlooks patient dangers. He stated that there are dangers associated with forgoing these medicines, such as the possibility — in certain cases, the near certainty — of anxiety, sadness, and even suicidal ideation.
Hinkle highlighted that although hormone therapies and puberty inhibitors are frequently used to treat non-transgender youngsters, some children can take them while others are prohibited by legislation.
Hinkle claimed that without medical attention, the three children named in the case "would suffer irreparable injury." In contrast, he stated, "the therapy will injure the defendants in no way and will only effect the patients themselves."
Requests for reaction from a governor's office spokeswoman did not immediately receive a response.
Civil rights organizations that claim that the statute discriminates against transgender individuals have won with the injunction. But because the three youngsters were the only ones covered by the decision, the statute is still in effect. Midway through 2023, there will be a trial.
In a preliminary order, Judge Robert Hinkle ruled that three transgender children may continue to receive care. The Republican governor Ron DeSantis signed the measure under challenge just before launching his candidacy for president.
"It's important to acknowledge the elephant in the room right away. Real gender identity exists. Hinkle stated in his decision that "the record makes this plain," and even a state witness concurred. Although it has been accessible for more than ten years and is supported by significant medical groups, transgender medical therapy for kids is coming under more and more criticism, according to Hinkle.
The law prohibits treating children with "GnRH agonists, commonly referred to as puberty blockers, and cross-sex hormones." The "treatments at question include GnRH agonists, commonly referred to as "puberty blockers," and cross-sex hormones," according to Hinkle.
In accordance with the situation, Hinkle said, "the overwhelming weight of medical authority supports the treatment of transgender patients with GnRH agonists and cross-sex hormones." Considering that "competent specialists have appropriately evaluated the children's medical problems and requirements in accordance with the well-established standards of care," he predicted that the plaintiffs will win their case.
Hinkle ordered a preliminary injunction against the defendants that said, in part, "the preliminarily enjoined parties shall not take any actions to hinder the delivery of GnRH agonists or cross-sex hormones" for the three kids.
Gender identity proponents "tend to dislike all things transgender and, as a result, oppose medical care that supports a person's transgender life," according to Hinkle.
Hinkle asserted that forbidding therapy overlooks patient dangers. He stated that there are dangers associated with forgoing these medicines, such as the possibility — in certain cases, the near certainty — of anxiety, sadness, and even suicidal ideation.
Hinkle highlighted that although hormone therapies and puberty inhibitors are frequently used to treat non-transgender youngsters, some children can take them while others are prohibited by legislation.
Hinkle claimed that without medical attention, the three children named in the case "would suffer irreparable injury." In contrast, he stated, "the therapy will injure the defendants in no way and will only effect the patients themselves."
Requests for reaction from a governor's office spokeswoman did not immediately receive a response.
Civil rights organizations that claim that the statute discriminates against transgender individuals have won with the injunction. But because the three youngsters were the only ones covered by the decision, the statute is still in effect. Midway through 2023, there will be a trial.
